ES2072252T3 - Estuche de material que contiene un polipeptido de amiloide de los islotes y/o anticuerpos dirigidos contra dicho polipeptido, y uso de dicho estuche de material. - Google Patents

Estuche de material que contiene un polipeptido de amiloide de los islotes y/o anticuerpos dirigidos contra dicho polipeptido, y uso de dicho estuche de material.

Info

Publication number
ES2072252T3
ES2072252T3 ES87850300T ES87850300T ES2072252T3 ES 2072252 T3 ES2072252 T3 ES 2072252T3 ES 87850300 T ES87850300 T ES 87850300T ES 87850300 T ES87850300 T ES 87850300T ES 2072252 T3 ES2072252 T3 ES 2072252T3
Authority
ES
Spain
Prior art keywords
case
polypeptide
directed against
islots
antibodies directed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87850300T
Other languages
English (en)
Inventor
Per Westermark
Kenneth H Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WESTERMARK P
University of Minnesota Twin Cities
University of Minnesota System
Original Assignee
WESTERMARK P
University of Minnesota Twin Cities
University of Minnesota System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20365860&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2072252(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by WESTERMARK P, University of Minnesota Twin Cities, University of Minnesota System filed Critical WESTERMARK P
Application granted granted Critical
Publication of ES2072252T3 publication Critical patent/ES2072252T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/843—Digestive system
    • Y10S530/845—Pancreas
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)

Abstract

EQUIPO DE MATERIAL QUE CONTIENE PROTEINA RELACIONADA CON AMILOIDE DE ISLETA PANCREATICO, SIENDO DICHA PROTEINA UNA SUBUNIDAD DE IA DESPOLIMERIZADO Y/O SIENDO UN ANTICUERPO DIRIGIDO CONTRA ELLA. ADEMAS, TAMBIEN SE DESCRIBE EL USO DE UN EQUIPO PARA OBTENER UN COMPLEJO (IAPP-IAPP-RECEPTOR).
ES87850300T 1986-10-08 1987-10-07 Estuche de material que contiene un polipeptido de amiloide de los islotes y/o anticuerpos dirigidos contra dicho polipeptido, y uso de dicho estuche de material. Expired - Lifetime ES2072252T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8604270A SE454299B (sv) 1986-10-08 1986-10-08 Sats innehallande polypeptid som finns i pankreasoamyloid och/eller antikroppar riktade mot polypeptiden

Publications (1)

Publication Number Publication Date
ES2072252T3 true ES2072252T3 (es) 1995-07-16

Family

ID=20365860

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87850300T Expired - Lifetime ES2072252T3 (es) 1986-10-08 1987-10-07 Estuche de material que contiene un polipeptido de amiloide de los islotes y/o anticuerpos dirigidos contra dicho polipeptido, y uso de dicho estuche de material.

Country Status (10)

Country Link
US (2) US5116948A (es)
EP (1) EP0263802B1 (es)
JP (2) JP2863527B2 (es)
AT (1) ATE123147T1 (es)
AU (1) AU8101287A (es)
CA (1) CA1341222C (es)
DE (1) DE3751316T2 (es)
ES (1) ES2072252T3 (es)
SE (1) SE454299B (es)
WO (1) WO1988002863A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298605A (en) * 1986-10-08 1994-03-29 Regents Of The University Of Minnesota Antibodies to islet amyloid polypeptide (IAPP) and subunits thereof
US5367052A (en) * 1987-04-27 1994-11-22 Amylin Pharmaceuticals, Inc. Amylin peptides
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
GB8709871D0 (en) * 1987-04-27 1987-06-03 Turner R C Peptides
US5266561A (en) * 1988-01-11 1993-11-30 Amylin Pharmaceuticals, Inc. Treatment of type 2 diabetes mellitus
US5175145A (en) * 1988-08-26 1992-12-29 Amylin Pharmaceuticals, Inc. Treatment of diabetes mellitus with amylin agonists
HU222249B1 (hu) * 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5352771A (en) * 1992-08-31 1994-10-04 Iowa State University Research Foundation Inc. Hydrolysis of peptide bonds using Pt (II) and Pd (II) complexes
US5376638A (en) * 1992-09-01 1994-12-27 Amylin Pharmaceuticals, Inc. Methods for treating renin-related disorders with amylin antagonists
AU2992295A (en) * 1994-07-13 1996-02-16 Auckland Uniservices Limited Therapeutic method and compounds of use therein
US6087129A (en) 1996-01-19 2000-07-11 Betagene, Inc. Recombinant expression of proteins from secretory cell lines
US6821954B2 (en) 1997-09-18 2004-11-23 Auckland Uniservices Limited Compounds and uses thereof in treating bone disorders
US6562836B1 (en) * 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
EP1774339A2 (en) * 2004-07-28 2007-04-18 F. Hoffmann-Roche AG Pancreatic polypeptide as target/marker of beta cell failure
DE102004051014A1 (de) * 2004-10-20 2006-04-27 Rwth Aachen Chemisch modifizierte Peptidanaloga
CN118955675A (zh) * 2019-02-22 2024-11-15 洛约拉马利蒙特大学 Iapp肽、包含其的药物组合物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE500044C2 (sv) * 1985-02-15 1994-03-28 Gambro Lundia Ab Peptidförening, antiserum framställt med användning av denna förening samt användning av föreningen
GB8516081D0 (en) * 1985-06-25 1985-07-31 Ciba Geigy Ag Assay & purification of amyloid components
GB8709871D0 (en) * 1987-04-27 1987-06-03 Turner R C Peptides

Also Published As

Publication number Publication date
DE3751316D1 (de) 1995-06-29
US5116948A (en) 1992-05-26
JP2939439B2 (ja) 1999-08-25
AU8101287A (en) 1988-05-06
EP0263802B1 (en) 1995-05-24
EP0263802A1 (en) 1988-04-13
WO1988002863A1 (en) 1988-04-21
SE454299B (sv) 1988-04-18
US5112945A (en) 1992-05-12
ATE123147T1 (de) 1995-06-15
JPH02500857A (ja) 1990-03-22
JPH09119929A (ja) 1997-05-06
CA1341222C (en) 2001-05-01
DE3751316T2 (de) 1996-02-01
SE8604270D0 (sv) 1986-10-08
JP2863527B2 (ja) 1999-03-03

Similar Documents

Publication Publication Date Title
ES2072252T3 (es) Estuche de material que contiene un polipeptido de amiloide de los islotes y/o anticuerpos dirigidos contra dicho polipeptido, y uso de dicho estuche de material.
ES2056817T3 (es) Transformacion de trichoderma.
SE7703004L (sv) Hentriakontapeptider och forfarande for deras framstellning
ES2068202T3 (es) Composicion liquida suavizante para prendas de ropa.
IT7825778A0 (it) Endoprotesi di articolazione costituita di materiali nonmetallici.
ATE160575T1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
GB1224868A (en) Sample capsule
IT7927473A0 (it) Composizioni di vetro e cementi incorporanti tali composizioni.
ES2106088T3 (es) Liposomas que proporcionan una ayuda timo-dependiente a antigenos de vacuna debiles.
ES2136598T3 (es) Inmunoanalisis de deteccion de anticuerpos monoclonales contra los peptidos de activacion de protrombina y sus productos de degradacion.
DK0538341T3 (da) EHV-4-gycoproteinvaccine.
IT1084176B (it) Dispositivo per la separazione di pezzi stampati ad iniezione e di materozze o simili
IT7921434A0 (it) Capo di vestiario guarnito eprocedimento per guarnire lo stesso.
DK528279A (da) Fremgangsmaade til isolering af hepatitis b e antigen eller antistof
FI891604A7 (fi) Perfluoripolyeettereiden käyttö vesipitoisen mikroemulsion muodossa kivimateriaalien suojaamiseen ilmakehän aineosien vaikutukselta
ES2039251T3 (es) Tratamiento del cabello.
ES478741A1 (es) Procedimiento para la preparacion de nuevos tetrahidrocarba-zoles y cis-hexahidrocarbazoles.
NO891713D0 (no) Monoklonale antistoffer til vevplasminogenaktivator (t-pa)
ES2093135T3 (es) Anticuerpos monoclonales contra el complejo plasmina-antiplasmina, procedimiento para su preparacion asi como su utilizacion.
IT1177379B (it) Derivati della sostanza p e di suoi frammenti
IT8023006A0 (it) Reagente per la determinazione della lipasi e suo impiego.
DK319384D0 (da) 1-0-alkyl-3-amino-propan-1,2-diol-2-0-phospholipider, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
DK192890D0 (da) 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme
AU560165B2 (en) Chromophoric peptides
ES2134781T3 (es) Polipeptidos con actividad de receptor dopaminergico humano, acidos nucleicos que codifican dichos polipeptidos y uso de dichos polipeptidos para el cribado de sustancias activas para dichos polipeptidos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 263802

Country of ref document: ES